alexa Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN α-2a /Ribavirin Combination Therapy

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Current and Future Trends in Surgery

New York, USA

International Conference on Food and Nutrition

Paris, France
Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN α-2a /Ribavirin Combination Therapy

Chronic hepatitis C infection (CHC) is acknowledged as a major health problem all over the world. The World Health Organization estimates that 3-4 million individuals are infected each year worldwide, with a global 170 million chronic HCV carriers at risk of developing liver cirrhosis and/or liver cancer. The most experienced treatment for chronic hepatitis C is pegylated interferon (PEGINF) and ribavirin (RBV) combination therapy. A variety of conditions ranging from endocrinopathies to different skin diseases have been described in only HCV infections and/or associated with IFN based therapy.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top